Entero Therapeutics, Inc. (NASDAQ ... amounting to approximately $7.4 million. The company contests the existence of any default related to the financial statements and is exploring strategic ...

Entero Therapeutics has named Richard Paolone as interim chief executive. Paolone is a Toronto-based securities lawyer with extensive experience in corporate finance, securities law and mergers ...